Director/PDMR Shareholding

RNS Number : 2742L

Hutchison China Meditech Limited

08 August 2013

 



Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Director's Shareholding

London: Thursday, 8 August 2013: Chi-Med received notification on 8 August 2013 that Mr Christopher Nash, Independent Non-executive Director of Chi-Med, purchased 8,506 ordinary shares of US$1.00 each in Chi-Med (the "Shares") at a price of GBP5.84 each on 7 August 2013.

Following this purchase, Mr Nash is beneficially interested in 26,506 Shares, representing approximately 0.05% of the current issued share capital of Chi-Med.

Ends

Enquiries

Chi-Med    Christian Hogg, CEO	Telephone:      [phone]
Panmure Gordon (UK) Limited    Richard Gray    Andrew Potts    Grishma Patel	Telephone:      [phone]
Citigate Dewe Rogerson    Anthony Carlisle    David Dible	Telephone:      [phone] Mobile:             [phone] Mobile:             [phone]

About Chi-Med

Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

 

END

 

 

RDSBBGDISGGBGXI